Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IIM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Enrolling By InvitationNCT06375993
What this trial is testing

Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease

Who this might be right for
Lupus NephritisAutoimmune DiseasesSystemic Sclerosis (SSc)+4 more
Adicet Therapeutics 180
Very early researchNot Yet RecruitingNCT07674147
What this trial is testing

RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
The Children's Hospital of Zhejiang University School of Medicine 30
Not applicableStudy completedNCT00055055
What this trial is testing

Study of Families With Twins or Siblings Discordant for Rheumatic Disorders

Who this might be right for
Rheumatoid ArthritisSystemic Lupus ErythematosusIdiopathic Inflammatory Myopathies
National Institute of Environmental Health Sciences (NIEHS) 1,056
Testing effectiveness (Phase 2)UnknownNCT05833711
What this trial is testing

Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy

Who this might be right for
DermatomyositisPolymyositisIdiopathic Inflammatory Myopathies
Immunoforge Co. Ltd. 39
Not applicableNot Yet RecruitingNCT07605637
What this trial is testing

Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005

Who this might be right for
Relapsed/Refractory Autoimmune Diseases
Beijing GoBroad Hospital 18
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Not applicableLooking for participantsNCT05454527
What this trial is testing

Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank

Who this might be right for
Inflammatory MyositisIdiopathic Inflammatory MyositisDrug-induced Inflammatory Myositis
Assistance Publique - Hôpitaux de Paris 4,000
Not applicableStudy completedNCT04637672
What this trial is testing

Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)

Who this might be right for
Inflammatory MyositisIdiopathic Inflammatory MyositisDrug-induced Inflammatory Myositis
Groupe Hospitalier Pitie-Salpetriere 1,273
Early research (Phase 1)Looking for participantsNCT07371468
What this trial is testing

GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 44
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Very early researchWithdrawnNCT06548620
What this trial is testing

RD06-04 in Patients With Active Autoimmune Diseases

Who this might be right for
SLESclerosisANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd.
Very early researchLooking for participantsNCT04561557
What this trial is testing

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Who this might be right for
Autoimmune DiseasesAutoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum Disorder+7 more
Tongji Hospital 36
Not applicableUnknownNCT04941547
What this trial is testing

Association Between Cancer and Anti-synthetase Syndrome

Who this might be right for
Antisynthetase Syndrome
Central Hospital, Nancy, France 200
Not applicableStudy completedNCT00971828
What this trial is testing

A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy

Who this might be right for
Idiopathic Inflammatory Myopathy
Northern Care Alliance NHS Foundation Trust 30
Very early researchLooking for participantsNCT06888960
What this trial is testing

Safety Study of CC312 in Autoimmune Disease Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3 more
CytoCares Inc 18
Not applicableNot Yet RecruitingNCT07737470
What this trial is testing

Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research

Who this might be right for
PericarditisTako-TSUBO CardiomyopathyMyocarditis+12 more
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782450
What this trial is testing

Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisIdiopathic Inflammatory Myositis+1 more
Pfizer 54
Testing effectiveness (Phase 2)UnknownNCT05400889
What this trial is testing

Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory Myopathies

Who this might be right for
Idiopathic Inflammatory Myopathies
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00106184
What this trial is testing

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
University of Pittsburgh 200
Early research (Phase 1)WithdrawnNCT06913608
What this trial is testing

Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)
Calibr, a division of Scripps Research
Next Page